- Home
- Publications
- Publication Search
- Publication Details
Title
Mineralocorticoid Receptor Antagonist for Renal Protection
Authors
Keywords
-
Journal
RENAL FAILURE
Volume 34, Issue 6, Pages 810-817
Publisher
Informa UK Limited
Online
2012-04-02
DOI
10.3109/0886022x.2012.672156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Kidneys and Aldosterone/Mineralocorticoid Receptor System in Salt-Sensitive Hypertension
- (2011) Shigeru Shibata et al. CURRENT HYPERTENSION REPORTS
- Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study
- (2011) Lene Boesby et al. PLoS One
- Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status
- (2010) Terry KW Ma et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria
- (2010) Katsuyuki Ando et al. HYPERTENSION RESEARCH
- Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats
- (2010) Kazi Rafiq et al. JOURNAL OF HYPERTENSION
- Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone Blockade
- (2009) Nitin Khosla et al. AMERICAN JOURNAL OF NEPHROLOGY
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review
- (2008) Andrew S. Bomback et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial
- (2008) Leszek Tylicki et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2and prostacyclin
- (2008) F E Xavier et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker
- (2008) Yoshiyuki FURUMATSU et al. HYPERTENSION RESEARCH
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started